Stock Events

Stock Events

KDventures AB 

$0.26
2
+$0+0% Friday 20:00

Statistics

Day High
0.26
Day Low
0.26
52W High
0.26
52W Low
0.26
Volume
2,500
Avg. Volume
0
Mkt Cap
68.91M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

1JanExpected
Q4 0
999
333
-333
-999
Expected EPS
N/A
Actual EPS
N/A

Financials

-11,877.62%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
490,835.14Revenue
-58.3MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow KDEVF. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
BridgeBio Pharma
BBIO
Mkt Cap13.29B
BridgeBio Pharma focuses on genetic diseases and targeted therapies, similar to Karolinska Development's investment in biotech and pharmaceutical companies.
Vertex Pharmaceuticals
VRTX
Mkt Cap107.83B
Vertex Pharmaceuticals is involved in creating transformative medicines for serious diseases, paralleling Karolinska's focus on high-impact medical conditions.
Sarepta Therapeutics
SRPT
Mkt Cap2.27B
Sarepta Therapeutics specializes in precision genetic medicine, competing in the same innovative biotechnology space as Karolinska Development.
Biomarin Pharmaceutical
BMRN
Mkt Cap10.45B
BioMarin Pharmaceutical develops and commercializes innovative biopharmaceuticals, similar to Karolinska's strategy in life sciences investments.
Alnylam Pharmaceuticals
ALNY
Mkt Cap39.51B
Alnylam Pharmaceuticals works on RNAi therapeutics, a cutting-edge approach in biotech where Karolinska Development also invests.
CRISPR Therapeutics
CRSP
Mkt Cap4.98B
CRISPR Therapeutics is a leader in gene editing technology, a field relevant to Karolinska Development's interest in groundbreaking medical technologies.
Novo Nordisk
NVO
Mkt Cap194.57B
Novo Nordisk is a global healthcare company with a focus on innovative treatments for diabetes and other serious chronic conditions, aligning with Karolinska's investment focus.
Regeneron Pharmaceuticals
REGN
Mkt Cap73.54B
Regeneron Pharmaceuticals is known for its scientific capabilities in biopharmaceuticals, directly competing with Karolinska's portfolio companies.
Bio-Techne
TECH
Mkt Cap8.61B
Bio-Techne develops, manufactures, and sells biotechnology products and clinical diagnostic controls, overlapping with Karolinska's biotech interests.

About

Karolinska Development AB (publ) is a venture capital firm specializing in investments in growth capital, seed stage, and early stage companies. It seeks to invest in pharmaceutical research and development, medical research, healthcare technology, gene research and development, drug delivery technologies, biotechnology, and life science tools and service sectors. The firm seeks to invest in the Nordic region with a focus on Sweden, Iceland, Norway, Finland, and Denmark. It prefers to be a lead investor in its portfolio companies however does consider co-investments also. It seeks to invest in up to five projects annually. Karolinska Development AB (publ) was founded in 2003 and is headquartered in Stockholm, Sweden.
Show more...
CEO
Dr. Viktor Drvota M.D., Ph.D.
Employees
8
Country
United States
ISIN
SE0002190926

Listings

Grey Market
US
KDEVF
MU
DE
2I9.MU
STU
DE
2I9.STU
LSE
GB
0P3C.LSE

0 Comments

Share your thoughts

FAQ

What is KDventures AB stock price today?▼
The current price of KDEVF is $0.26 USD — it has increased by +0% in the past 24 hours. Watch KDventures AB stock price performance more closely on the chart.
What is KDventures AB stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange KDventures AB stocks are traded under the ticker KDEVF.
What is KDventures AB market cap?▼
Today KDventures AB has the market capitalization of 68.91M
What were KDventures AB earnings last quarter?▼
KDEVF earnings for the last quarter are -0.02 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is KDventures AB revenue for the last year?▼
KDventures AB revenue for the last year amounts to 490,835.14 USD.
What is KDventures AB net income for the last year?▼
KDEVF net income for the last year is -58.3M USD.
How many employees does KDventures AB have?▼
As of May 06, 2026, the company has 8 employees.
In which sector is KDventures AB located?▼
KDventures AB operates in the Health & Wellness sector.
When did KDventures AB complete a stock split?▼
KDventures AB has not had any recent stock splits.
Where is KDventures AB headquartered?▼
KDventures AB is headquartered in Solna, United States.